Table 3.
No. of patients* (n = 650) | |
---|---|
Tumour size (mm) (n = 580) † | 13 (7–25) |
No. of lymph nodes resected (n = 490) † | 10 (4–25) |
No. of tumour‐positive lymph nodes (n = 531) † | 0 (0–3) |
Lymph node ratio (n = 455) † | 0 (0–0·23) |
T category | |
T1a | 213 (32·8) |
T1b | 186 (28·6) |
T2 | 111 (17·1) |
T3 | 76 (11·7) |
T4a | 29 (4·5) |
T4b | 3 (0·5) |
Tx | 3 (0·5) |
Unknown | 29 (4·5) |
N category | |
N0 | 283 (43·5) |
N1a | 106 (16·3) |
N1b | 130 (20·0) |
Nx | 88 (13·5) |
Unknown | 43 (6·6) |
M category | |
M0 | 359 (55·2) |
M1 | 37 (5·7) |
Mx | 162 (24·9) |
Unknown | 92 (14·2) |
Tumour stage | |
I | 289 (44·5) |
II | 81 (12·5) |
III | 97 (14·9) |
IVA | 108 (16·6) |
IVB | 1 (0·2) |
IVC | 37 (5·7) |
Unknown | 37 (5·7) |
With percentages in parentheses unless indicated otherwise;
values are median (i.q.r.).